Kate de Ridder is Investment Director at Bridgewest Ventures, a globally leading deep tech incubator and venture investor head quartered in New Zealand. Kate brings strong technical and commercial expertise in advancing science-based ventures from early development through scale and market entry.

Bridgewest has a 25-year track record of building and scaling innovative deep tech companies, with several portfolio companies successfully listing on NASDAQ. Their current life sciences portfolio includes Wellington based BioOra which focuses on automating and scaling CAR-T cell immunotherapy manufacturing which has considered public listing as a pathway.